LETTER TO JMG

Wolcott-Rallison syndrome: pathogenic insights into neonatal diabetes from new mutation and expression studies of EIF2AK3

S Brickwood¹, D T Bonthron², L I Al-Gazali³, K Piper¹, T Hearn¹, D I Wilson¹, N A Hanley¹

¹ Division of Human Genetics, Southampton University, Southampton, UK
² Molecular Medicine Unit, University of Leeds, St James’s University Hospital, Leeds, UK
³ Department of Paediatrics, FMHS, UAE University, Al Ain, UAE

Correspondence to:
Correspondence to:
Dr Neil A Hanley, Division of Human Genetics, Southampton General Hospital, Tremona Road, Southampton SO16 6YD, UK;
n.a.hanley@soton.ac.uk

Keywords: diabetes mellitus; gene expression; mutation

The first 150 words of the full text of this article appear below.

Wolcott-Rallison syndrome (OMIM 226980) is a rare autosomal recessive disorder characterised by permanent insulin requiring diabetes developing in the newborn period or early infancy, an early tendency to skeletal fractures, and spondyloepiphyseal dysplasia.1–8 The syndrome results from mutations in the gene encoding the eukaryotic translation initiation factor 2- kinase 3 (EIF2AK3, also called PERK or PEK).9 This enzyme phosphorylates EIF2A at Ser51 to regulate the synthesis of unfolded proteins in the endoplasmic reticulum.10 Targeted disruption of the Eif2ak3 gene in mice also causes diabetes because of the accumulation of unfolded proteins triggering ß cell apoptosis.11 12 Although these murine models have provided significant insight into the pathogenesis of Wolcott-Rallison syndrome, only three human cases have been characterised genetically.8 9 Here, we report genetic analysis of two further cases, and demonstrate new features of the expression pattern of human EIF2AK3 that offer . . . [Full text of this article]

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Rubio-Cabezas, O., Patch, A.-M., Minton, J. A. L., Flanagan, S. E., Edghill, E. L., Hussain, K., Balafrej, A., Deeb, A., Buchanan, C. R., Jefferson, I. G., Mutair, A., the Neonatal Diabetes International Collaborative, , Hattersley, A. T., Ellard, S. (2009). Wolcott-Rallison Syndrome Is the Most Common Genetic Cause of Permanent Neonatal Diabetes in Consanguineous Families. J. Clin. Endocrinol. Metab. 94: 4162-4170 [Abstract] [Full Text]  
• Aguilar-Bryan, L., Bryan, J. (2008). Neonatal Diabetes Mellitus. Endocr. Rev. 29: 265-291 [Abstract] [Full Text]  
• Stanik, J., Gasperikova, D., Paskova, M., Barak, L., Javorkova, J., Jancova, E., Ciljakova, M., Hlava, P., Michalek, J., Flanagan, S. E., Pearson, E., Hattersley, A. T., Ellard, S., Klimes, I. (2007). Prevalence of Permanent Neonatal Diabetes in Slovakia and Successful Replacement of Insulin with Sulfonylurea Therapy in KCNJ11 and ABCC8 Mutation Carriers. J. Clin. Endocrinol. Metab. 92: 1276-1282 [Abstract] [Full Text]  
• Porter, J R, Barrett, T G (2005). Monogenic syndromes of abnormal glucose homeostasis: clinical review and relevance to the understanding of the pathology of insulin resistance and {beta} cell failure. J. Med. Genet. 42: 893-902 [Abstract] [Full Text]  
• Kloting, N., Wilke, B., Kloting, I. (2004). Phenotypic and genetic analyses of subcongenic BB.SHR rat lines shorten the region on chromosome 4 bearing gene(s) for underlying facets of metabolic syndrome. Physiol. Genomics 18: 325-330 [Abstract] [Full Text]  
• Senee, V., Vattem, K. M., Delepine, M., Rainbow, L. A., Haton, C., Lecoq, A., Shaw, N. J., Robert, J.-J., Rooman, R., Diatloff-Zito, C., Michaud, J. L., Bin-Abbas, B., Taha, D., Zabel, B., Franceschini, P., Topaloglu, A. K., Lathrop, G. M., Barrett, T. G., Nicolino, M., Wek, R. C., Julier, C. (2004). Wolcott-Rallison Syndrome: Clinical, Genetic, and Functional Study of EIF2AK3 Mutations and Suggestion of Genetic Heterogeneity. Diabetes 53: 1876-1883 [Abstract] [Full Text]